Global Biosimilars and Biologics Market Surges: $46.11 Billion Market Forecast for 2028 - Industry Trends and Strategic Analysis

Dublin, Feb. 02, 2024 (GLOBE NEWSWIRE) -- The "Global Biosimilars and Biologics Market (2023-2028) by Product, Application, and Geography, Competitive Analysis, Impact of Covid-19, Ansoff Analysis" report has been added to's offering.

The comprehensive review of the Global Biosimilars and Biologics Market reveals a market that is projected to grow significantly, with estimates showing it will double in size from USD 22.05 billion in 2023 to USD 46.11 billion by 2028, displaying a robust Compound Annual Growth Rate (CAGR) of 15.90%.

Market Insights and Dynamics

The in-depth market report articulates key industry dynamics, with a distinct focus on product innovation and competitive landscape. The dynamic market conditions articulated within the report underscore the significant impact of technological progress, regulatory frameworks, and emerging applications on market trajectories. The study also sheds light on the consumer behavior patterns and evolving competitive strategies that stand to shape the biosimilars and biologics sector through 2028.

Segment Analysis and Geographical Outlook

Further examination within the report divulges critical segmentation by product and application, enhancing understanding of market concentration across the globe, and offering insights into the regions presenting the highest growth potential. A detailed scrutiny on Alfa Interferons, Beta Interferons, and Epoetins among other products is presented, each illustrating a unique role in the healthcare landscape, particularly in areas such as immunology and oncology

. Recent Market Developments

Notable advancements, including significant product launches, are also dissected within the report's narrative, informing stakeholders of the latest market entrants and novel growth strategies by leading industry players.

  • Market Trends and Consumer Insights
  • Strategic Market Expansion Analysis
  • Detailed Competitive Landscape and Company Profiles
  • In-Depth Segmentation by Product, Application, and Geography
  • Comprehensive Analysis Using Porter's 5 Forces and Ansoff Matrix
  • Impact of COVID-19 on Market Dynamics

Strategic Framework and Competitive Positioning

The report encompasses a proprietary analytical tool, the Competitive Quadrant, to showcase the industry positioning of key players based on various analytical dimensions. The Ansoff Analysis embedded in the report serves as a strategic tool for stakeholders looking to understand potential risks and frame growth strategies.

Market Recommendations and Forecasts

The publication concludes with expert recommendations, directing companies towards strategies that could solidify their market presence. With an extensive historical and projected market analysis, this report serves as an invaluable resource for entities seeking to navigate the complex landscape of the biosimilars and biologics market.

This meticulous market analysis sets out to inform and guide strategic decision-making for incumbents and new entrants alike, providing a thorough assessment of market conditions, competitive strategies, and growth opportunities in the essential sector of biosimilars and biologics, with an aim to aid businesses in harnessing the potential for innovation, competitiveness, and market expansion.

Key Attributes

Report AttributeDetails
No. of Pages183
Forecast Period2023 - 2028
Estimated Market Value (USD) in 2023$22.05 Billion
Forecasted Market Value (USD) by 2028$46.11 Billion
Compound Annual Growth Rate15.9%
Regions CoveredGlobal

Companies Mentioned

  • Amgen, Inc.
  • Biocon Limited
  • Celltrion Inc.
  • Dr. Reddy’s Laboratories
  • Eli Lilly & Co.
  • F.Hoffmann-La Roche, Ltd.
  • Fresenius Kabi AG
  • Merck KGaA
  • Mylan, Inc.
  • Novartis AG
  • Pfizer, Inc.
  • Sandoz International GmbH
  • Stada Arzneimittel AG

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Global Biosimilars and Biologics Market

Contact Data